close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar923294Point77
Implied share price

Buy Undervalued by 1210778.4%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AGN
Allergan, Inc.
Change
292541.26 23.69 392789.88 10.5 7.02 72.28
All amounts in millions
from last financial year
         
Implied Share Price $923294.77 $46527.50 $3247678.91 $2304080.52 $1404685.48
Market Cap 18,291 1,229,412 169,063 131,592 120,680
Net Debt -371 20 2,276 7,255 15,530
Enterprise Value (EV) 18,961 1,229,432 171,339 72,436 136,310
Revenue 4,048 44 24,890 34,109 13,062
EBITDA 800 3 16,315 10,317 1,886
Percent 19.8 % 7.1 % 65.5 % 30.2 % 14.4 %
EBIT 332 1 15,265 6,528 -942
Percent 8.2 % 3.6 % 61.3 % 19.1 % -7.2 %
Balance Sheet          
Total Assets 10,913 58 34,664 97,392 52,529
Total Liabilities 3,326 56 19,238 41,272 24,198
Shareholders Equity 7,586 2 15,426 56,120 28,331.1

Comments

No comments yet. Login to comment.